No Detail Found!

Effect of injectable Erythropoietin and Hemaodialysis on blood hemoglobin, serum Creatinine and blood urea levels in chronic renal failure Patients.

Author(s)
S. Khaliq Nucear Institute for Agriculture & Biology (NIAB), Faisalabad, Pakistan
K. Rehman Nucear Institute for Agriculture & Biology (NIAB), Faisalabad, Pakistan
T. M. Chaudhary Nucear Institute for Agriculture & Biology (NIAB), Faisalabad, Pakistan
N. Yaqoob Nucear Institute for Agriculture & Biology (NIAB), Faisalabad, Pakistan
A. Ashraf Nucear Institute for Agriculture & Biology (NIAB), Faisalabad, Pakistan
M. S. Shah Nucear Institute for Agriculture & Biology (NIAB), Faisalabad, Pakistan
N. G. Nabi Nucear Institute for Agriculture & Biology (NIAB), Faisalabad, Pakistan
T. Humma Nucear Institute for Agriculture & Biology (NIAB), Faisalabad, Pakistan
Abstract
The administration of recombinant human erythropoietin (r-HuEPO) is in trials all over the world to stimulate the process of erythroposies and hence to cover the state of anemia. In this study two-month treatment of erythropoietin (EPO) was administered subcutaneously along with hemodialysis to chronic renal failure (CRF) patients and found it very effective in raising blood hemoglobin levels and to cure anemia. After two-month treatment, blood Hb levels increased from 7.20±0.43 g/dI to 9.60±0.47 g/dl while blood urea and serum creatinine levels decreased from 202.9±29.9 mg/dI and 10.06 ±1.44 mg/dl to 147.4 ±4.48 mg/dI and 7.37±2.24 mg/dl respectively.
Publication Details
Page(s) 699-703
DOI DOI not available
Published Journal: International Journal of Biology and Biotechnology, Volume: 1, Issue: 4, Year: 2004

Request the full text from PASTIC

0

Citations

0

Downloads

50

Views